RCUS — Arcus Biosciences Cashflow Statement
0.000.00%
Last trade - 00:00
- $1.64bn
- $672.12m
- $117.00m
- 53
- 14
- 36
- 26
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -84.7 | -123 | 52.8 | -267 | -307 |
Depreciation | |||||
Non-Cash Items | 7.54 | 22.8 | 62.8 | 76 | 64 |
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.125 | 208 | -376 | 623 | -71 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -73.5 | 111 | -256 | 438 | -306 |
Capital Expenditures | -1.93 | -3.06 | -26.1 | -6 | -24 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 61.1 | -431 | 22.2 | -407 | 218 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 59.2 | -434 | -3.87 | -413 | 194 |
Financing Cash Flow Items | 0 | — | 5 | 10 | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | 1.12 | 439 | 237 | 33 | 33 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -13.1 | 115 | -22.7 | 58 | -79 |